Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
0.6000
-0.0290 (-4.61%)
At close: Aug 15, 2025
-62.38%
Market Cap 63.31M
Revenue (ttm) n/a
Net Income (ttm) 57.52M
Shares Out 105.51M
EPS (ttm) 2.79
PE Ratio 0.22
Forward PE 0.94
Dividend n/a
Ex-Dividend Date n/a
Volume 696,533
Average Volume 217,962
Open 0.6290
Previous Close 0.6290
Day's Range 0.5800 - 0.6290
52-Week Range 0.4800 - 3.3100
Beta 1.53
RSI 49.49
Earnings Date Aug 28, 2025

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 10
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.